Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Literature DB >> 24921212

World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Douglas R LaBrecque¹, Zaigham Abbas, Frank Anania, Peter Ferenci, Aamir G Khan, Khean-Lee Goh, Saeed S Hamid, Vasily Isakov, Maribel Lizarzabal, Manuel M Peñaranda, Juan F R Ramos, Shiv Sarin, Davor Stimac, Alan B R Thomson, Muhammed Umar, Justus Krabshuis, Anton LeMair.

Abstract

Entities: Disease

Mesh：

Year: 2014 PMID： 24921212 DOI： 10.1097/MCG.0000000000000116

Source DB: PubMed Journal: J Clin Gastroenterol ISSN： 0192-0790 Impact factor: 3.062

Keyword Cloud
Cited

× No keyword cloud information.

120 in total

1. Visual Liver Score to Stratify Non-Alcoholic Steatohepatitis Risk and Determine Selective Intraoperative Liver Biopsy in Obesity.

Authors: Geraldine J Ooi; Paul R Burton; Arul Earnest; Cheryl Laurie; William W Kemp; Peter D Nottle; Catriona A McLean; Stuart K Roberts; Wendy A Brown
Journal: Obes Surg Date: 2018-02 Impact factor: 4.129

Review 2. Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine.

Authors: Mazen Noureddin; José M Mato; Shelly C Lu
Journal: Exp Biol Med (Maywood) Date: 2015-04-13

Review 3. Genome-based nutrition: an intervention strategy for the prevention and treatment of obesity and nonalcoholic steatohepatitis.

Authors: Sonia Roman; Claudia Ojeda-Granados; Omar Ramos-Lopez; Arturo Panduro
Journal: World J Gastroenterol Date: 2015-03-28 Impact factor: 5.742

4. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.

Authors: Palanivelu Praveenraj; Rachel M Gomes; Saravana Kumar; Purushothaman Karthikeyan; Annapoorni Shankar; Ramakrishnan Parthasarathi; Palanisamy Senthilnathan; Subbiah Rajapandian; Chinnusamy Palanivelu
Journal: Obes Surg Date: 2015-11 Impact factor: 4.129

5. Trihalomethane exposure and biomonitoring for the liver injury indicator, alanine aminotransferase, in the United States population (NHANES 1999-2006).

Authors: James B Burch; Todd M Everson; Ratanesh K Seth; Michael D Wirth; Saurabh Chatterjee
Journal: Sci Total Environ Date: 2015-04-02 Impact factor: 7.963

10. Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression.

Authors: Enas A Abd El-Haleim; Ashraf K Bahgat; Samira Saleh
Journal: World J Gastroenterol Date: 2016-03-14 Impact factor: 5.742

World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

1. Visual Liver Score to Stratify Non-Alcoholic Steatohepatitis Risk and Determine Selective Intraoperative Liver Biopsy in Obesity.

Review 2. Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine.

Review 3. Genome-based nutrition: an intervention strategy for the prevention and treatment of obesity and nonalcoholic steatohepatitis.

4. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.

5. Trihalomethane exposure and biomonitoring for the liver injury indicator, alanine aminotransferase, in the United States population (NHANES 1999-2006).

6. Low serum adiponectin is a predictor of progressing to nonalcoholic fatty liver disease.

7. Cost-utility analysis of nonalcoholic steatohepatitis screening.

Review 8. Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.

9. Nonalcoholic fatty liver disease: a frequent condition in type 2 diabetic patients.

10. Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression.